BDBM50330097 CHEMBL1234565::N-(4-(5-ethyl-3-(pyridin-3-yl)-1H-pyrazol-1-yl)phenyl)nicotinamide::N-[4-(5-ethyl-3-pyridin-3-yl-1H-pyrazol-1-yl)phenyl]pyridine-3-carboxamide
SMILES: CCc1cc(nn1-c1ccc(NC(=O)c2cccnc2)cc1)-c1cccnc1
InChI Key: InChIKey=CCAFHMPMIJBDRP-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EBifunctional epoxide hydrolase 2 (Homo sapiens (Human)) | BDBM50330097 (CHEMBL1234565 | N-(4-(5-ethyl-3-(pyridin-3-yl)-1H-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL MMDB PC cid PC sid PDB UniChem Patents Similars | PDB Article PubMed | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharmaceuticals Inc. Curated by ChEMBL | Assay Description Inhibition of human Ephx2 after 30 mins by fluorescence polarization assay | Bioorg Med Chem Lett 20: 6379-83 (2010) Article DOI: 10.1016/j.bmcl.2010.09.095 BindingDB Entry DOI: 10.7270/Q2V69JT7 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) |